Abstract:Background: Surgery is still the standard treatment for breast lesions such as in situ ductal carcinoma (DCIS); however, its survival benefit is minimal, particularly for low-grade DCIS. Surgical complications and related depression status can adversely affect patients' quality of life. Approximately 25% of breast cancer (BC) cases are in situ forms, with DCIS making up 90% of these. Low and intermediate-grade DCIS often grow slowly and do not always progress clinically significant diseases. Identifying non-invasive lesions could help prevent overtreatment. In this context, new diagnostic tools like vacuum-assisted excision (VAE) could enhance the management of these conditions. Methods: The prospective VACIS study explores the role of VAE in ensuring the absence of pathology at subsequent surgery and reducing the diagnostic underestimation of breast biopsies for microcalcifications. Patients with suspicious breast microcalcifications up to 15 mm, who are candidates for stereotactic biopsy, will be enrolled and randomised into two groups. The control group will complete the biopsy with typical sampling, aiming to collect some microcalcifications from the target, while the experimental group will focus on the complete removal of the biopsy target (confirmed by mammography on the biopsy table), followed by a second sequence of cleaning samples. Radiograms will confirm lesion removal. Pathologic outcomes at surgery will be compared between the groups, and the percentage of underestimation will be assessed. The sample size is calculated to be 70 patients per group, using statistical tests and multivariate logistic models to detect a significant difference in the absence of pathology. Data collected will include patient age, lesion characteristics, and details of the biopsy, pathology and surgery. Discussion: Current surgical treatments for low-and sometimes intermediate-grade DCIS offer limited survival benefits and may hurt patients' quality of life due to surgery-related complications and associated depression. These lesions often grow slowly and might not become clinically significant, suggesting a need to avoid overtreatment. Improved diagnostics procedures, such as VAE, could help distinguish non-invasive from potentially invasive lesions, reduce biopsy underestimation, enable personalised management and optimise treatment strategies. This study hypothesises that VAE could be a viable alternative to surgery, capable of removing pathology during the biopsy procedure. Clinical trial registration: Clinicaltrials.gov, identifier NCT05932758.

A mimic of breast carcinoma 1-year post vacuum-assisted excision of a benign breast lesion

Repeated Lumps and Infections: A Case Report on Breast Augmentation Complications

Urinary Catheter-Directed Breast-Conserving Surgery for Incidentally Discovered Breast Cancer After Vacuum-assisted Breast Biopsy (VABB) Therapeutic Excision

Mammotome® Biopsy System for the Resection of Breast Lesions: Clinical Experience in Two High-Volume Teaching Hospitals

Effectiveness of percutaneous vacuum-assisted excision (VAE) of breast lesions of uncertain malignant potential (B3 lesions) as an alternative to open surgical biopsy

High-Risk Breast Lesions Diagnosed by Ultrasound-Guided Vacuum-Assisted Excision

Mucocele-like lesions of the breast - A radiological and clinicopathological analysis

Epidermal cyst of the breast treated by vacuum-assisted biopsy

Vanishing Act: A Case Report of Missing Breast Tumour Marker

Repair of Breast Defect by Transfer of a Contralateral Internal Mammary Artery Perforator Flap

Ultrasound-Guided Laser Ablation After Excisional Vacuum-Assisted Breast Biopsy for Small Malignant Breast Lesions: Preliminary Results

Metaplastic breast cancer masquerading as a recurrent haematoma: A case report

Minimal invasive complete excision of benign breast tumors using a three-dimensional ultrasound-guided mammotome vacuum device

The clinical application of high-resolution ultrasound-guided mammotome minimally invasive biopsy system in resection of breast lesions

Efficacy and safety of percutaneous ultrasound—guided vacuum—assisted excision for the treatment of clinical benign breast lesions larger than 3 cm: a retrospective cohort study

Vacuum-assisted biopsy system for breast lesions: a potential therapeutic approach

Recurrence Rates of Benign Phyllodes Tumors After Surgical Excision and Ultrasonography-Guided Vacuum-Assisted Excision

Exploring non-surgical alternatives for low to intermediate-grade in situ ductal carcinoma of the breast using vacuum-assisted excision: the VACIS protocol

Imaging surveillance for the detection of ipsilateral local tumor recurrence in patients who underwent oncoplastic breast-conserving surgery with acellular dermal matrix: abbreviated MRI versus conventional mammography and ultrasonography

Ultrasound-guided 8-Gauge vacuum-assisted excision for selected B3 breast lesions: a preliminary experience

Primary Extranodal Follicular T-Cell Lymphoma and Ductal Breast Carcinoma Diagnosed by a Magnetic Resonance Imaging-Guided Vacuum-Assisted Biopsy: A Case Report